THE INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-4 (IGFBP-4)-IGFBP-4 PROTEASE SYSTEM IN NORMAL HUMAN OSTEOBLAST-LIKE CELLS - REGULATION BY TRANSFORMING GROWTH-FACTOR-BETA
Sk. Durham et al., THE INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-4 (IGFBP-4)-IGFBP-4 PROTEASE SYSTEM IN NORMAL HUMAN OSTEOBLAST-LIKE CELLS - REGULATION BY TRANSFORMING GROWTH-FACTOR-BETA, The Journal of clinical endocrinology and metabolism, 79(6), 1994, pp. 1752-1758
Insulin-like growth factor-binding protein-4 (IGFBP-4) is secreted by
normal human osteoblast-like (hOB) cells and acts as a potent inhibito
r of IGF action. hOB cells also secrete a protease, which requires IGF
s for activation and specifically cleaves IGFBP-4. To study the regula
tion of this IGFBP-4 protease, hOB cells from 26 different adult donor
s were cultured in serum-free medium for 24 h in the absence or presen
ce of hormones and other factors known to regulate bone growth. hOB ce
ll-conditioned medium (hOB-CM) was collected for measurement of IGFBP-
4 protease activity in a cell-free assay. This assay involved incubati
on of hOB-CM (50 mu L) without or with IGF-II at 37 C for 6 h. IGF-II-
activated IGFBP-4 hydrolysis was assessed by Western Ligand blotting a
nd quantitated using laser densitometry. Conditioned medium from all h
OB cells examined exhibited IGFBP-4 protease activity. PTH, GH, insuli
n, calcitonin, glucocorticoids, sex steroids, 1,25-dihydroxyvitamin D-
3 and epidermal growth factor had no significant effect on IGF-depende
nt IGFBP-4 protease activity. In comparison, hOB-CM from cells treated
with transforming growth factor-beta (TGF beta) exhibited significant
ly augmented IGF-II-dependent proteolysis of endogenous IGFBP-4. Enhan
ced proteolysis of exogenous IGFBP-4 was also demonstrated: 1) 92% of
recombinant human IGFBP-4 added to conditioned medium from TGF beta-tr
eated hOB cells was hydrolyzed during the assay in the presence of IGF
-II compared to 45% of recombinant human IGFBP-4 added to control hOB-
CM; and 2) increased radiolabeled IGFBP-4 fragments were generated in
conditioned medium from TGF beta-treated hOB cells compared with contr
ol hOB-CM in the presence of IGF-II. In addition to its effect on IGFB
P-4 proteolysis, TGF beta treatment decreased IGFBP-4 messenger ribonu
cleic acid expression, as measured by Northern analysis. Our results i
ndicate that the IGFBP-4-IGFBP-4 protease system in hOB cells can be c
ontrolled by two of the most abundant local growth factors for bone (I
GF-II and TGF beta), with each acting via different mechanisms. Regula
tion of IGFBP-4 availability may play an important role in the modulat
ion of bone cell responsiveness to IGFs.